| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/12/2002 | CA2449814A1 Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder |
| 12/12/2002 | CA2449777A1 Animal model for allergy |
| 12/11/2002 | EP1264837A1 Conjugation-stabilized polypeptide compositions |
| 12/11/2002 | EP1264604A2 Improvements in or relating to contrast agents |
| 12/11/2002 | EP1263954A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 12/11/2002 | EP1263803A1 Embolic compositions |
| 12/11/2002 | EP1263802A1 Hydrogel biomedical articles |
| 12/11/2002 | EP1263801A1 Tissue bulking and coating compositions |
| 12/11/2002 | EP1263776A2 Peptides targeting specifically tumor-derived endothelial cells |
| 12/11/2002 | EP1263478A2 Functional radiographic imaging methods and agents |
| 12/11/2002 | EP1263477A1 Simultaneous multimodal measurement of physiological function |
| 12/11/2002 | EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 12/11/2002 | EP1263428A2 Free radical scavengers for the treatment of premature birth |
| 12/11/2002 | EP1263325A1 Embolic agents visible under ultrasound |
| 12/11/2002 | EP1061956B1 Manganese chelates with high relaxivity in serum |
| 12/11/2002 | EP1051421B1 Compounds containing boron for electron microscopy and for boron neutron-capture therapy |
| 12/11/2002 | CN1384760A Near infrared fluorescent contrast agent and fluorescence imaging |
| 12/10/2002 | US6493570 Administering a halogenated xanthene to a patient prior to imaging, a portion of said halogenated xanthene being retained in said diseased tissue; and imaging said patient using a detected signal from said halogenated xanthene |
| 12/10/2002 | US6492500 Modified bioluminescent proteins and their use |
| 12/10/2002 | US6492420 Such as methyl ester; more effective than free form at slowing tumor growth |
| 12/10/2002 | US6492331 NL8 tie ligands homologues |
| 12/10/2002 | US6491983 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 12/10/2002 | US6491895 Pulmonary and cardiac vasculature mri images are obtained by delivering xenon-129 gas to a patient via inhalation, exciting the dissolved phase gas with a large flip angle pulse and generating a corresponding image |
| 12/10/2002 | US6491893 Compounds for targeting and imaging infection and inflammation |
| 12/10/2002 | CA2093431C Ionically cross-linked polymeric microcapsules |
| 12/06/2002 | WO2001096344A1 Novel expanded porphyrins and process for the synthesis thereof |
| 12/05/2002 | WO2002097437A1 Assay for beta cell toxic macrolides |
| 12/05/2002 | WO2002097060A2 Carbohydrate-associated proteins |
| 12/05/2002 | WO2002096932A1 Transporters and ion channels |
| 12/05/2002 | WO2002096896A1 Biologically active methylene blue derivatives |
| 12/05/2002 | WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 12/05/2002 | WO2002096470A1 A population of hoxb8 mutants and uses in identifying agents for treating repetitive behaviors |
| 12/05/2002 | WO2002096417A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis |
| 12/05/2002 | WO2002096367A2 Targeted multivalent macromolecules |
| 12/05/2002 | WO2002096366A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 12/05/2002 | WO2002096292A1 Wrinkle indicator tape strip and method of using the same |
| 12/05/2002 | WO2002042321A3 Mixed fibrils |
| 12/05/2002 | US20020183502 Oligonucleotides for use in the human therapeutics and diagnostics |
| 12/05/2002 | US20020183386 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 12/05/2002 | US20020182683 Vascular endothelial growth factor 2 |
| 12/05/2002 | US20020182583 Design and planning system for improving the survival rate of injected structures |
| 12/05/2002 | US20020182153 Method for detecting chitin-containing organisms |
| 12/05/2002 | US20020182152 Ocular diagnosis of Alzheimer's Disease |
| 12/05/2002 | US20020182149 Radiation transparent strip with adhesive surface; measuring efficiency of antiaging cosmetics |
| 12/05/2002 | US20020182147 Vitronectin receptor antagonist pharmaceuticals |
| 12/05/2002 | US20020182112 In vivo method for measuring binding of chemical actives to skin or specific constituents of skin |
| 12/05/2002 | DE10119522A1 Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel Preparation and application of a suspension composition with an ultrasonic contrast agent |
| 12/05/2002 | CA2448953A1 Assay for beta cell toxic macrolides |
| 12/05/2002 | CA2448570A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis |
| 12/05/2002 | CA2448562A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 12/05/2002 | CA2448148A1 Carbohydrate-associated proteins |
| 12/05/2002 | CA2447662A1 Transporters and ion channels |
| 12/05/2002 | CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 12/04/2002 | EP1262490A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 12/04/2002 | EP1262179A1 Photodynamic therapy for selectively closing neovasa in eyeground tissue |
| 12/04/2002 | EP1261381A2 Use of radiopharmaceuticals and intraoperative radiation probe |
| 12/04/2002 | EP1261333A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 12/04/2002 | EP1261280A2 Methods of detecting cancer using cellular autofluorescence |
| 12/04/2002 | CN1383452A Compsns. and methods for treating cells having double minute DNA |
| 12/04/2002 | CN1382493A Diarylprophin photosensitizer and its preparing process and usage |
| 12/03/2002 | US6489459 Hop=homolog of presenilin; isolated nucleic acid, vector and host cell; related to alzheimer's disease |
| 12/03/2002 | US6489302 Of varous drugs (such as anticancer agents) that make use of glucose transporter to deliver drugs to site of action (such as across blood-brain barrier) more efficiently, thereby reducing side effects |
| 12/03/2002 | US6489123 Labelling and selection of molecules |
| 12/03/2002 | US6489119 Analgesic screening method and composition |
| 12/03/2002 | US6488910 Methods for dissolving hyperpolarized 129 Xe gas using microbubbles |
| 11/28/2002 | WO2002095022A2 Sequence-specific dna binding compounds and their use in targeting telomeres and other dna sequences |
| 11/28/2002 | WO2002094990A2 Receptors and membrane-associated proteins |
| 11/28/2002 | WO2002094873A2 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use |
| 11/28/2002 | WO2002094378A2 Increased functional activity and/or expression of abc transporters protects against the loss of dopamine neurons associated with parkinson's disease |
| 11/28/2002 | WO2002094215A2 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vimyl acetate as surface stabilizers |
| 11/28/2002 | WO2002094191A2 Detection of alzheimer's amyloid by magnetic resonance imaging |
| 11/28/2002 | WO2002057741A3 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 11/28/2002 | WO2002024924A3 Protein phosphatases |
| 11/28/2002 | WO2001051095A3 Paramagnetic dota derivatives, pharmaceutical agents containing the same, methods for the production thereof and their use for the mr imaging of necrosis and infarction |
| 11/28/2002 | US20020178459 Genetically engineered mammal for use in the treatment of muscle and liver disorders |
| 11/28/2002 | US20020177704 Nitroimidazole substituted porphyrin complex |
| 11/28/2002 | US20020177582 For diagnosing and treating urogenital disorders associated with atrophic vaginitis in symptomatic women having vaginal pH of 4.5 or above |
| 11/28/2002 | US20020177242 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 11/28/2002 | US20020177147 Mdr1 variants and methods for their use |
| 11/28/2002 | US20020176880 A polymeric hydrogel material that permits cellular ingrowth and has controlled rate of expansion optimized for delivery through microcatheter or catheter without need for a nonaqueous solvent or coating |
| 11/28/2002 | US20020176823 Use as diagnostic agents and therapeutic agents |
| 11/28/2002 | US20020176822 MR signal-emitting coatings |
| 11/28/2002 | US20020176821 Each compound composition is tested by contacting it with 10-1000 non-mammalian multi-cellular organisms and determining effect of compound composition on organisms; for screening of libraries of combinatorially produced compounds |
| 11/28/2002 | US20020176820 Functional expression of, and assay for, functional cellular receptors in vivo |
| 11/28/2002 | CA2447338A1 Receptors and membrane-associated proteins |
| 11/27/2002 | EP1259815A1 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma |
| 11/27/2002 | EP1259814A1 Bcmp-7 as marker for diagnosis of breast cancer |
| 11/27/2002 | EP1259808A2 Method for labeling individual cells |
| 11/27/2002 | EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 11/27/2002 | EP1259604A1 Bcmp 84, a protein associated to breast cancer |
| 11/27/2002 | EP1259532A1 Bile acids conjugates with metal ion chelates and the use thereof |
| 11/27/2002 | EP1259497A1 Novel quinoline ligands and metal complexes for diagnosis and therapy |
| 11/27/2002 | EP1028758A4 Methods for treating prostate tumors using radioactive compositions |
| 11/27/2002 | EP1028757A4 Radioactive embolizing compositions |
| 11/27/2002 | CN1382063A Administering gravity segregation dispersion by continuous infusion |
| 11/27/2002 | CN1382062A Targeting multimeric imaging agents through multilocus binding |
| 11/26/2002 | US6486133 Methods for inducing localized vascular development and enhancing the repair of a wound in the mammamian dermis |
| 11/26/2002 | US6485985 Processes and compounds for magnetorelaxometric detection of analytes and their use |
| 11/26/2002 | US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 11/26/2002 | US6485705 Dry pulverulent formulation comprising at least one film forming surfactant and a hydrophilic stabilizer in the presence of entrapable gas and an aqueous carrier phase mixable with said dry formulation |